The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-4329
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2026
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Fateeva V.V.

Sechenov First Мoscow State Medical University, Moscow, Russia

Vorob'eva O.V.

Kafedra nervnykh bolezneĭ fakul'teta poslevuzovskogo professional'nogo obrazovaniia vracheĭ

Cerebral markers of endothelial dysfunction in chronic brain ischemia

Authors:

Fateeva V.V., Vorob'eva O.V.

More about the authors

Journal: S.S. Korsakov Journal of Neurology and Psychiatry. 2017;117(4): 107‑111

DOI: 10.17116/jnevro201711741107-111

Read: 1985 times

Download PDF (RU)
Contact the author
Table of contents

CEREBRAL MARKERS OF ENDOTHELIAL DYSFUNCTION IN CHRONIC BRAIN ISCHEMIA
CEREBRAL MARKERS OF ENDOTHELIAL DYSFUNCTION IN CHRONIC BRAIN ISCHEMIA

To cite this article:

Fateeva VV, Vorob'eva OV. Cerebral markers of endothelial dysfunction in chronic brain ischemia. S.S. Korsakov Journal of Neurology and Psychiatry. 2017;117(4):107‑111. (In Russ.)
https://doi.org/10.17116/jnevro201711741107-111

Подписка 2026 Журнал неврологии и психиатрии им. С.С. Корсакова (S.S. Korsakov Journal of Neurology and Psychiatry)
МСФ на ЯМ
Использование инфографики авторами научных работ
Close metadata
Recommended articles:
Expe­rience of using reamberin for correction of cognitive status in patients with chro­nic cere­bral ischemia. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(5):84-88
Quantitative and qualitative asse­ssment of the complete blood count in patients with obstructive sleep apnea and chro­nic ischemia. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(5):95-102
Targets of rational neuroprotection in the therapy of chro­nic cere­bral ischemia and the possibilities of achieving them. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(8):96-101
The rela­tionship between the right heart and the thickness of the common caro­tid artery intima-media complex in patients with chro­nic cere­bral ischemia. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(12-2):21-29
Headache and cognitive impairment in patients with chro­nic cere­bral ischemia. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(12):78-81
Abstract:

A review of the main markers of endothelial dysfunction in chronic cerebral ischemia is presented. The quantitative changes in the level of endothelial dysfunction markers in chronic cerebral ischemia help to evaluate the efficacy of preventive and therapeutic pharmacological activities. The results of clinical trials have demonstrated that the course use of divazа in patients with chronic cerebral ischemia leads to improvement of both clinical indicators and laboratory markers for normalization of cerebral ischemia and endothelial dysfunction.

Keywords:

chronic cerebral ischemia
laboratory markers of endothelial dysfunction
divaza

Authors:

Fateeva V.V.

Sechenov First Мoscow State Medical University, Moscow, Russia

Vorob'eva O.V.

Kafedra nervnykh bolezneĭ fakul'teta poslevuzovskogo professional'nogo obrazovaniia vracheĭ

Close metadata

References:

  1. Kanda K, Matsuda T. Behavior of arterial wall cells cultured on periodically stretched substrates. Cell Transplant. 1993;2:475-484.
  2. Mitra S, Goyal T, Mehta JL. Oxidized LDL, LOX-1 and atherosclerosis. Cardiovasc Drugs Ther Int Soc Cardiovasc Pharmacother. 2011;25:419-429. doi:10.1007/s10557-011-6341-5
  3. Tilton RG, Chang KC, LeJeune WS et al. Role for nitric oxide in the hyperpermeability and hemodynamic changes induced by intravenous VEGF. Investig Ophthalmol Vis Sci. 1999;40:689-696.
  4. Michetti F et al. The S100B protein in biological fluids: more than a lifelong biomarker of brain distress. Journal of Neurochemistry. 2012;120(5):644-659. doi:10.1111/j.1471-4159.2011.07612.x
  5. Donato R et al. S100B’s double life: Intracellular regulator and extracellular signal. Biochimica et Biophysica Acta (BBA) — Molecular Cell Research. 2009;1793(6):1008-1022.
  6. Michetti F et al. The nervous system-specific S-100 antigen in cerebrospinal fluid of multiple sclerosis patients. Neuroscience Letters. 1979;11(2):171-175.
  7. Korfias S et al. Serum S-100B Protein as A Biochemical Marker of Brain Injury: A Review of Current Concepts. CMC. 2006;13(30):3719-3731.
  8. Saleem M, Herrmann N, Swardfager W, Eisen R, Lanctôt KL. Inflammatory Markers in Mild Cognitive Impairment: A Meta-Analysis. Arosio B, editor. JAD. 2015;3:47(3):669-679. doi:10.3233/JAD-130830
  9. Eikelenboom P, van Exel E, Hoozemans JJM, Veerhuis R, Rozemuller AJM, van Gool WA. Neuroinflammation — An Early Event in Both the History and Pathogenesis of Alzheimer’s Disease. Neurodegenerative Dis. S. Karger AG; 2010;7(1-3):38-41.
  10. Gorelick PB, Scuteri A, Black SE, DeCarli C, Greenberg SM, Iadecola C et al. Vascular Contributions to Cognitive Impairment and Dementia: A Statement for Healthcare Professionals From the American Heart Association/American Stroke Association. Stroke. Ovid Technologies (Wolters Kluwer Health). 2011;42(9):2672-2713. doi:10.1161/STR.0b013e3182299496
  11. Eremenko SI. Encephalopathy (etiology, pathogenesis, morbid anatomy, clinic, examination of disability, treatment guidelines). Blagoveshchensk: Amur State Medical Academy; 2008. (In Russ.).
  12. Suarez EC, Sundy JS, Erkanli A. Depressogenic vulnerability and gender-specific patterns of neuro-immune dysregulation: What the ratio of cortisol to C-reactive protein can tell us about loss of normal regulatory control. Brain, Behavior, and Immunity. Elsevier BV. 2015;44:137-147.
  13. Matsuzaka H, Maeshima H, Kida S, Kurita H, Shimano T, Nakano Y et al. Gender Differences in Serum Testosterone and Cortisol in Patients with Major Depressive Disorder Compared with Controls. The International Journal of Psychiatry in Medicine. SAGE Publications. 2013;46(2):203-221.
  14. Pace TWW, Raison CL, Miller AH. Neuroendocrine — Immune Interactions: Implications for Health and Behavior. Hormones, Brain and Behavior. Elsevier BV. 2009;2597-2634.
  15. Besedovsky HO. Immune-neuro-endocrine interactions: facts and hypotheses. Endocrine Reviews. The Endocrine Society. 1996;17(1):64-102. doi:10.1210/edrv-17-1-64
  16. Levin YI. Depression and sleep. Therapist. 2008;8:29-32. (In Russ.).
  17. Motivala SJ, Sarfatti A, Olmos L, Irwin MR. Inflammatory Markers and Sleep Disturbance in Major Depression. Psychosomatic Medicine. Ovid Technologies (Wolters Kluwer Health). 2005;67(2):187-194. doi:10.1097/01.psy.0000149259.72488.09
  18. Hyong Jin Choa, Teresa E. Seeman, Catarina I. Kiefe, Diane S. Lauderdale, Michael R. Irwin. Sleep disturbance and longitudinal risk of inflammation: Moderatinginfluences of social integration and social isolation in the CoronaryArtery Risk Development in Young Adults (CARDIA) study. Brain Behav Immun. 2015;1-8. doi:10.1016/j.bbi.2015.02.023
  19. Michetti F, Massaro A, Murazio M. The nervous system-specific S-100 antigen in cerebrospinal fluid of multiple sclerosis patients. Neuroscience Letters. 1979;11(2):171-175.
  20. Chukanova EI Bogolepova AN, AS Chukanova Experience in the use of the drug in the treatment of divaza tsrebrovaskulyarnoy failure. Journal of Neurology and Psychiatry. 2015;115:6:110-114. (In Russ.). doi:10.17116/jnevro201511561?-?
  21. Fateeva VV, Kolokolov O.V, Zakharova NB, Malein A.Yu., Abramov TP, Fisun AV Kolokolova AM Makarov NS Sleep disturbance and cognitive functions as a manifestation of chronic cerebral ischemia and pathogenetic basis of their correction. attending physician. 2016;5:1-6. (In Russ.).
  22. Fateeva VV, Schumacher GI, Vorobiev EN, MA Horev, Voskanyan LR The efficacy and safety of the drug Divaza in the treatment of patients with chronic ischemia of brain. Journal of Neurology and Psychiatry. 2017;117:2:32-37. (In Russ.). doi:10.17116/jnevro201711721?-?
  23. Kamchatnov PR, Vorobyov OV Rachina AP. Correction of emotional and cognitive impairment in patients with chronic cerebral ischemia. Journal of Neurology and Psychiatry. 2014;114:4:2-57. (In Russ.).
Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.